From: First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
Number | % | ||
---|---|---|---|
Patients | 120 | ||
Male | 68 | 56.7 | |
Female | 52 | 43.3 | |
Median age (range) in years | 73 (65–86) | ||
Histology | Rhabdomyosarcoma | 8 | 6.7 |
Angiosarcoma | 17 | 14.2 | |
Liposarcoma | 10 | 8.3 | |
Myofibroblastic tumour | 8 | 6.7 | |
Synovial | 2 | 1.7 | |
Undifferentiated | 36 | 30 | |
Leiomyosarcoma | 33 | 27.5 | |
Other | 6 | 5 | |
Disease status | Locally advanced | 36 | 30 |
Metastatic | 84 | 70 | |
Sites of metastatic disease | Lung | 61 | |
Liver | 15 | ||
Bone | 7 | ||
Other | 14 | ||
Age Adjusted Charlson Index | 2 | 7 | 5.8 |
3 | 17 | 14.2 | |
4 | 4 | 3.3 | |
5 | 3 | 2.5 | |
6 | 5 | 4.2 | |
8 | 24 | 20 | |
9 | 37 | 30.8 | |
10 | 10 | 8.3 | |
>10 | 13 | 10.8 | |
Anaemia* | 65 | 54.2 | |
LDH > 250U/L | 71 | 59.2 | |
Lymphopenia (<1×10 9 /L) | 34 | 28.3 | |
Hypoalbuminemia (<35 g/L) | 48 | 40 |